Lionco Pharmaceutical Group Co.,Ltd. (603669.SS)
CNY 6.69
(-3.04%)
CNY 6.69
(-3.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 196.83 Million | 289.26 Million | 740.32 Million | 1 Billion | 1.63 Billion | 1.66 Billion |
| Cost of Revenue | 109.87 Million | 93.11 Million | 152.68 Million | 155.65 Million | 223.15 Million | 201.99 Million |
| Gross Profit | 86.95 Million | 196.14 Million | 587.64 Million | 845.34 Million | 1.41 Billion | 1.46 Billion |
| Operating Expenses | 235.93 Million | 360.26 Million | 518.01 Million | 652 Million | 1.18 Billion | 1.26 Billion |
| Selling, General and Administrative Expenses | 136.64 Million | 249.78 Million | 440.5 Million | 642.73 Million | 1.11 Billion | 1.23 Billion |
| Research and Development Expenses | 32.59 Million | 31.62 Million | 22.77 Million | 20.36 Million | 38.04 Million | 24.29 Million |
| Other Expenses | 66.69 Million | 78.85 Million | 54.73 Million | -11.1 Million | 38.11 Million | -4.81 Million |
| Cost and Expenses | 345.81 Million | 453.37 Million | 670.7 Million | 807.65 Million | 1.4 Billion | 1.47 Billion |
| Operating Income | -148.98 Million | -164.11 Million | 71.12 Million | 180.74 Million | 222.62 Million | 209 Million |
| Interest Expense | 3.7 Million | 5.83 Million | 15.51 Million | 11.25 Million | 13.58 Million | 2.21 Million |
| Income Tax Expense | 540.83 Thousand | 6.94 Million | 4.57 Million | 19.18 Million | 21.33 Million | 21.48 Million |
| Earnings before Tax | -150.95 Million | -188.8 Million | 70.48 Million | 179.25 Million | 222.92 Million | 204.19 Million |
| Net Income | -151.49 Million | -195.74 Million | 65.9 Million | 160.07 Million | 201.59 Million | 182.7 Million |
| Earnings Per Share Basic | -0.21 | -0.27 | 0.09 | 0.22 | 0.28 | 0.26 |
| Earnings Per Share Diluted | -0.21 | -0.27 | 0.09 | 0.21 | 0.28 | 0.26 |
| Weighted Average Shares Outstanding | 721.4 Million | 718.45 Million | 715.37 Million | 713.44 Million | 713.44 Million | 710.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 721.4 Million | 718.45 Million | 774.41 Million | 762.25 Million | 713.44 Million | 710.51 Million |
| Gross Margin | 0.44 | 0.68 | 0.79 | 0.84 | 0.86 | 0.88 |
| EBIT Margin | -0.46 | -0.42 | 0.19 | 0.24 | 0.17 | 0.14 |
| Profit Margin | -0.77 | -0.68 | 0.09 | 0.16 | 0.12 | 0.11 |
| EBITDA | -90.79 Million | -134.37 Million | 132.71 Million | 251.86 Million | 288.77 Million | 249.41 Million |
| Earnings Before Tax Margin | -0.76 | -0.57 | 0.10 | 0.18 | 0.14 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 88.78 Million | 63.84 Million | 76.2 Million | 46.16 Million | 196.83 Million | 37.74 Million |
| Cost of Revenue | 53.83 Million | 53.62 Million | 33 Million | 25.71 Million | 104.96 Million | 21.82 Million |
| Gross Profit | 34.95 Million | 10.22 Million | 43.19 Million | 20.44 Million | 91.86 Million | 15.91 Million |
| Operating Expenses | 62.63 Million | 39.15 Million | 60.64 Million | 60.16 Million | 202.72 Million | 26.56 Million |
| Selling, General and Administrative Expenses | 58.28 Million | 33.38 Million | 55.84 Million | -15.09 Million | - | 73.57 Million |
| Research and Development Expenses | 4.34 Million | 5.75 Million | 4.77 Million | 7.89 Million | - | 7.92 Million |
| Other Expenses | -3200.00 | -18.39 Thousand | -24.69 Thousand | -146.26 Thousand | -1.97 Million | -774.55 Thousand |
| Cost and Expenses | 116.46 Million | 92.77 Million | 93.65 Million | 85.87 Million | 307.69 Million | 48.39 Million |
| Operating Income | -27.68 Million | -28.93 Million | -17.44 Million | -54.98 Million | -148.98 Million | -26.22 Million |
| Interest Expense | 4.96 Million | 1.37 Million | 162.79 Thousand | 765.49 Thousand | 3.7 Million | 927.9 Thousand |
| Income Tax Expense | -22.65 Thousand | -646.49 Thousand | -143.76 Thousand | -220.81 Thousand | 540.83 Thousand | -142.26 Thousand |
| Earnings before Tax | -2.42 Million | -20.46 Million | -12.7 Million | -55.13 Million | -150.95 Million | -27 Million |
| Net Income | -6.48 Million | -24.35 Million | -16.04 Million | -54.91 Million | -151.49 Million | -26.86 Million |
| Earnings Per Share Basic | -0.01 | -0.03 | -0.02 | -0.08 | - | -0.04 |
| Earnings Per Share Diluted | -0.01 | -0.03 | -0.02 | -0.08 | - | -0.04 |
| Weighted Average Shares Outstanding | 721.24 Million | 721.23 Million | 721.23 Million | 656.8 Million | 721.4 Million | 721.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 721.24 Million | 721.23 Million | 721.23 Million | 656.8 Million | 721.4 Million | 721.23 Million |
| Gross Margin | 0.39 | 0.16 | 0.57 | 0.44 | 0.47 | 0.42 |
| EBIT Margin | 0.03 | -0.29 | -0.18 | -0.86 | - | -0.31 |
| Profit Margin | -0.07 | -0.38 | -0.21 | -1.19 | -0.77 | -0.71 |
| EBITDA | 2.54 Million | -18.68 Million | -13.96 Million | -39.71 Million | - | -11.75 Million |
| Earnings Before Tax Margin | -0.31 | -0.45 | -0.23 | -1.19 | -0.76 | -0.69 |
DOMO
RN70
4644
002457
WLDBF
603004